Kylee Maclachlan

46PUBLICATIONS
227CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Haematological tumoursMedical mycologyPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jun 12, 2026
Genomic features do not account for differences in multiple myeloma risk by ancestry.

|May 01, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

|Apr 20, 2026
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Feb 24, 2026
Prognosis and patterns of progression in smoldering multiple myeloma.

Theresia Akhlaghi, Kylee H Maclachlan, Adriana Wiggins

|Feb 17, 2026
IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand

Pageof 8

Frequent Collaborators

33 joint publications

Malin L Hultcrantz

26 joint publications

Urvi Shah

24 joint publications

Neha Korde

23 joint publications

Saad Z Usmani